Thomas B. Tomasi

Q: What Schools Are Affiliated With Thomas B. Tomasi

Thomas B. Tomasi is affiliated with the following schools: University of Vermont, Mayo Clinic College of Medicine and Science, University of New Mexico

Thomas B. Tomasi's AcademicInfluence.com Rankings

Thomas B. Tomasi

Biology

#6069

World Rank

#8702

Historical Rank

Immunology

#307

World Rank

#318

Historical Rank

biology Degrees

Download Badge

Biology

Thomas B. Tomasi's Degrees

PhD Immunology University of California, San Diego
Doctorate Medicine University of California, San Diego

Why Is Thomas B. Tomasi Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Thomas B. Tomasi's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

CHARACTERISTICS OF AN IMMUNE SYSTEM COMMON TO CERTAIN EXTERNAL SECRETIONS (1965) (933)
Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythmatosus. (1969) (458)
Suppression of the immune response by alpha-fetoprotein on the primary and secondary antibody response (1975) (347)
THE HUMAN SECRETORY IMMUNOGLOBULIN SYSTEM: IMMUNOHISTOLOGICAL LOCALIZATION OF γA, SECRETORY "PIECE," AND LACTOFERRIN IN NORMAL HUMAN TISSUES (1969) (329)
Structure and function of immunoglobulin A. (1972) (306)
Gamma-Globulins: Quantitative Relationships in Human Serum and Nonvascular Fluids (1963) (290)
Gamma globulin complexes in rheumatoid arthritis and certain other conditions. (1961) (279)
Activation of MHC Class I, II, and CD40 Gene Expression by Histone Deacetylase Inhibitors1 (2000) (274)
THE SELECTIVE OCCURRENCE OF γ1A GLOBULINS IN CERTAIN BODY FLUIDS (1963) (267)
Host defense mechanisms at mucosal surfaces. (1981) (235)
Evidence for complement activation via the alternate pathway in skin diseases, I. Herpes gestationis, systemic lupus erythematosus, and bullous pemphigoid. (1973) (219)
Dicer is regulated by cellular stresses and interferons. (2009) (200)
Human immunoglobulin A. (1968) (199)
Immune parameters in athletes before and after strenuous exercise (1982) (188)
Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells (2008) (182)
MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components. (2008) (178)
miRNA regulation of cytokine genes. (2009) (151)
The immune system of secretions. (1976) (146)
Possible relationship of rheumatoid factors and pulmonary disease. (1962) (132)
A Low Molecular Weight Immunoglobulin Antigenically Related to 19 S IgM. (1967) (131)
The human female reproductive tract: Immunohistological localization of γA, γG, γM, secretory “piece,” and lactoferrin (1970) (127)
Isolation of an enzyme from Streptococcus sanguis which specifically cleaves IgA. (1974) (125)
Structure and function of mucosal antibodies. (1970) (120)
Immunopathology of bullous pemphigoid. Basement membrane deposition of IgE, alternate pathway components and fibrin. (1974) (117)
The effect of exercise on secretory and natural immunity. (1987) (115)
Immunohistologic Studies of Human Lacrimal Gland: Localization of Immunoglobulins, Secretory Component and Lactoferrin (1973) (114)
Epigenetic regulation of immune escape genes in cancer (2006) (114)
A transforming growth factor beta 2 (TGF-beta 2)-like immunosuppressive factor in amniotic fluid and localization of TGF-beta 2 mRNA in the pregnant uterus (1990) (111)
Salivary gland immunoglobulin and rheumatoid factor synthesis in Sjögren's syndrome. Natural history and response to treatment. (1972) (110)
Immunoglobulin M: pentameric Fcmu fragments released by trypsin at higher temperatures. (1970) (101)
Structure and function of alpha-fetoprotein. (1977) (96)
THE LIFE SPAN OF IgA PLASMA CELLS FROM THE MOUSE INTESTINE (1973) (88)
Human immunoglobulin A: production of an Fc fragment by an enteric microbial proteolytic enzyme. (1973) (85)
Exosomes from Plasmacytoma Cells as a Tumor Vaccine (2004) (85)
In vitro studies of inflammatory bowel disease. Surface receptors of the mononuclear cell required to lyse allogeneic colonic epithelial cells. (1976) (84)
Suppressor cells and IgA deficiency. (1978) (82)
Mechanisms of immune regulation at mucosal surfaces. (1983) (81)
Structure and Function of Immunoglobulin A (Part 1 of 3) (1972) (80)
Secretory γA in normal urine (1968) (77)
Bullous pemphigoid antigen: isolation from normal human skin. (1977) (77)
Mucosal immunity: The origin and migration patterns of cells in the secretory system. (1980) (77)
Regulation of MHC class II gene expression in macrophages by hematopoietic colony-stimulating factors (CSF). Induction by granulocyte/macrophage CSF and inhibition by CSF-1 (1989) (72)
An immunological assessment of patients with anorexia nervosa. (1981) (72)
Characteristics of secretory immune system in human middle ear: implications in otitis media. (1974) (72)
Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expression (1998) (70)
Studies on human intestinal immunoglobulin A. (1971) (68)
Histone acetylation regulates the cell type specific CIITA promoters, MHC class II expression and antigen presentation in tumor cells. (2005) (67)
ACTIVITY OF DISSOCIATED AND REASSOCIATED 19S ANTI-γ-GLOBULINS (1964) (66)
Lymphocyte cytotoxicity and inhibition studied with autologous liver cells: observations in chronic active liver disease and the primary biliary cirrhosis syndrome. (1976) (65)
The discovery of secretory IgA and the mucosal immune system. (1992) (65)
The Binding of α-1 Antitrypsin to Human IgA (1974) (62)
Binding of α-foetoprotein to murine T cells (1975) (61)
The Heat Shock Protein 90-CDC37 Chaperone Complex Is Required for Signaling by Types I and II Interferons* (2006) (60)
Evidence for the activation of complement via the alternate pathway in skin diseases. II. Dermatitis herpetiformis. (1974) (60)
Humoral aspects of mucosal immunity (1985) (59)
Demonstration of antimyelin antibodies by immunofluorescence in Guillain-Barré syndrome. (1971) (57)
Decreased secretory immunoglobulins following intense endurance exercise (1989) (55)
Prostaglandins in the human fallopian tube. (1974) (55)
Serum Gamma-globulins in Acute and Chronic Liver Diseases (1964) (53)
Antibodies to human albumin in cirrhotic sera. (1974) (50)
The Gamma A Globulins: First Line of Defense (1967) (49)
Immunohistologic Localization of Immunoglobulins, Secretory Component, and Lactoferrin in the Developing Human Fetus 1 (1972) (48)
PRODUCTION OF A RUNTING SYNDROME AND SELECTIVE γA DEFICIENCY IN MICE BY THE ADMINISTRATION OF ANTI-HEAVY CHAIN ANTISERA (1973) (47)
An epigenetic vaccine model active in the prevention and treatment of melanoma (2007) (46)
Aqueous hum or proteins in uveitis. Immunoelectrophoretic and gel diffusion studies on normal and pathological human aqueous humor. (1961) (44)
Low-molecular-weight rheumatoid factor. (1963) (44)
An epigenetically altered tumor cell vaccine (2004) (43)
The immunochemistry of middle ear effusions. (1974) (43)
Histone deacetylase regulation of immune gene expression in tumor cells (2008) (42)
Enzymatic oxidation of polyamines. Relationship to immunosuppressive properties (1981) (40)
TGF-beta 2 gene and protein expression in maternal and fetal tissues at various stages of murine development. (1993) (40)
Lymphoid interstitial pneumonia and autoerythrocyte sensitization syndrome. A case with deposition of immunoglobulins on the alveolar basement membrane. (1974) (39)
Secretory otitis media: a histopathologic and immunochemical report. (1972) (38)
Immunohistological localization of γG, γA, γM secretory piece and lactoferrin in the human female genital tract (1970) (38)
Natural Antibodies of Human Serum, Saliva, and Urine Reactive with Escherichia coli ∗ (1968) (38)
Differential expression and regulation of the c-src and c-fgr protooncogenes in myelomonocytic cells. (1987) (36)
Studies on extracellular proteases of Streptococcus sanguis. Purification and characterization of a human IgA1 specific protease. (1978) (36)
Immunoglobulin M: Fixation of Human Complement by the Fc Fragment (1972) (35)
SERUM FACTORS WHICH SUPPRESS THE IMMUNE RESPONSE (1977) (34)
Characterization of the serum and secretory immune systems of the cow and sheep. (1969) (33)
Deficiency of immunoglobulin A in intestinal disease. (1968) (33)
Suppressive factors in amniotic fluid and newborn serum: Is α-fetoprorein involved? (1978) (33)
Isolation, chemical, and physical properties of alpha-1-antitrypsin. (1976) (33)
Activation of the classical complement pathway by Fc fragment of human IgA. (1977) (33)
Analytical Review: Human Gamma Globulin (1965) (32)
Mechanism of immunoglobulin A polymerization. (1975) (32)
DNA Alkylating Agents Alleviate Silencing of Class II Transactivator Gene Expression in L1210 Lymphoma Cells1 (2002) (32)
Primary ovarian, thyroidal and adrenocortical deficiencies simulating pituitary insufficiency, associated with diabetes mellitus. (1962) (31)
A Transforming Growth Factor 02 ( TGF-X 32 )-like Immunosuppressive Factor in Amniotic Fluid and Localization of TGF-$ 2 mRNA in the Pregnant Uterus (30)
Lymphoid Interstitial Pneumonia with Monoclonal Gammopathy1 (1968) (30)
Secretory immunoglobulins. (1968) (30)
Separation of epidermis from dermis with sodium thiocyanate. (1977) (29)
Dicer and microRNA expression in multiple sclerosis and response to interferon therapy (2016) (29)
THE SELECTIVE OCCURENCE OF GAMMA-1A GLOBULINS IN CERTAIN BODY FLUIDS. (1963) (28)
Activation of multiple transcription factors and fos and jun gene family expression in cells exposed to a single electric pulse. (1995) (27)
Serum and secretory immunoglobulins of the rat. (1970) (27)
A precipitation reaction between human serum and a soluble tissue component. (1961) (27)
The synthesis of secretory component by the human thymus. (1972) (27)
Immunoglobulins and antibody activity in the intestine and serum in cholera. I. Analysis of immunoglobulins in cholera stool. (1970) (26)
Comparative studies of vertebrate immunoglobulins. (1972) (26)
A monoclonal IgM protein with antibody-like activity for human albumin. (1974) (25)
Inhibition of sensitization of T‐cells by alpha‐fetoprotein (1975) (24)
Lymphoid interstitial pneumonia with monoclonal gammopathy. (1968) (24)
Human antibodies against bovine immunoglobulin M in IgA deficient sera. (1971) (24)
Antibodies of nasal and parotid secretions of ragweed-allergic subjects. (1970) (24)
Bovine secretory component. Isolation, molecular size and shape, composition, and NH2-terminal amino acid sequence. (1976) (23)
Cytokine production by human soft tissue sarcomas: implications for immunosuppression within the tumour bed. (1996) (22)
Dicer in immune cell development and function (2014) (21)
Suppression of antibody responses to topically applied antigens by ultraviolet light irradiation. Induction of phototolerance (1984) (21)
Differential regulation of TGF-β2 by hormones in rat uterus and mammary gland (1996) (20)
Serum amyloid P component induces neuronal apoptosis and β-amyloid immunoreactivity (2003) (20)
BIDIRECTIONAL TRANSPORT OF HORSERADISH PEROXIDASE IN PROXIMAL TUBULE OF NECTURUS KIDNEY (1971) (20)
Identification of "J" chain in a homogeneous canine IgA immunoglobulin. (1972) (19)
Mucosal antibodies in respiratory and gastrointestinal disease. (1970) (19)
Apoptotic and necrotic cells induced by different agents vary in their expression of MHC and costimulatory genes. (2005) (19)
AUTOANTIBODIES AGAINST THYROID AND ADRENAL TISSUE IN A PATIENT WITH MULTIPLE, PRIMARY ENDOCRINE DEFICIENCIES. (1963) (19)
Combined immune deficiency, autoantibody formation, and mucocutaneous candidiasis. (1973) (18)
Polymer modification of antibody to eliminate immune complex and Fc binding. (1988) (18)
Effects of transforming growth factor-beta on bone marrow macrophage Ia expression induced by cytokines. (1995) (18)
Alpha-fetoprotein synthesis by murine lymphoid cells in allogeneic reactions (1976) (17)
Spatial distribution of histone methylation during MHC class II expression. (2008) (17)
Lactoferrin in synovial fluid of patients with inflammatory arthritis. (1972) (17)
Role of transforming growth factor‐β1 in the suppressed allostimulatory function of AIDS patients (1998) (16)
Studies on the chymotrypsin C and papain fragments of human immunoglobulin M. (1969) (16)
Selective Transport of γA 1 (1969) (16)
Immunosuppressive factors in mouse amniotic fluid and neonate serum. (1978) (15)
Mild hyperthermia enhances the expression and induces oscillations in the Dicer protein (2013) (15)
Oral tolerance. (1980) (14)
Repression of MHC class II gene transcription in trophoblast cells by novel single‐stranded DNA binding proteins (1997) (14)
Secretory YA in Normal Urine (1968) (14)
Regulation of IgA expression by isotype-specific T cells and soluble binding factors. (1986) (14)
Mucosal Immune System (1976) (14)
Suppression of lymphocyte proliferation by copper-albumin chelates. (1984) (13)
Stimulation of reduced lysozyme regeneration by transferrin and lactoferrin. (1977) (13)
On the mechanisms of transport and biological significance of antibodies in external secretions. (1969) (12)
Production of an Fc fragment from human immunoglobulin A by an IgA-specific bacterial protease. (1974) (12)
Effect of transforming growth factor-β1 on microglial MHC-class II expression (2000) (12)
ISOLATION OF 7S AND 19S GAMMA GLOBULINS. (1964) (12)
High temperature trypsinolysis of human IgA: Isolation of the Fcα fragment☆ (1976) (12)
Regulation of the mucosal IGA response--an overview. (1989) (12)
Production of a noncovalently bonded pentamer of immunoglobulin M: relationship of J chain. (1973) (12)
PROLONGATION OF MALE SKIN GRAFT SURVIVAL IN FEMALE MICE TREATED WITH AMNIOTIC FLUID (1988) (11)
Workshop 67 – Secretory Immunoglobulins (1971) (11)
Human J-chain: isolation and molecular weight studies. (1974) (11)
MHC class II regulation by epigenetic agents and microRNAs (2010) (10)
The epigenetic regulation of Dicer and microRNA biogenesis by Panobinostat (2017) (10)
Restoration of immune response gene induction in trophoblast tumor cells associated with cellular senescence. (2009) (9)
Modulation of the assembly of immunoglobulin subunits by J chain. (1974) (9)
Aging and the regulation of immune reactivity (1975) (9)
Antisera to the secretory component recognize the murine Fc receptor for IgA. (1989) (9)
1 – Introduction: An Overview of the Mucosal System (1994) (9)
Secondary structure in solution of two anti‐HIV‐1 hammerhead ribozymes as investigated by two‐dimensional 1H 500 MHz NMR spectroscopy in water (1995) (8)
Identification of the major immunoglobulin heavy chain poly A+ RNA in murine lymphoid tissue. (1986) (8)
Secretory gamma-A in normal urine. (1968) (8)
Chromatin-immune connections: regulation of MHC and other genes. (2000) (8)
The major histocompatibility complex class II transactivator is differentially regulated by interferon-γ and transforming growth factor-β in microglial cells (2006) (8)
Fragments of human G immunoglobulins produced by a porcine pancreatic esterase. (1971) (8)
Effector Sites on Antibodies (1979) (7)
Binding of alpha-foetoprotein to murine T cells. (1975) (7)
The major histocompatibility complex class II transactivator is differentially regulated by interferon-gamma and transforming growth factor-beta in microglial cells. (2006) (7)
Urinary gammaA rheumatoid factor. (1969) (7)
Immunoglobulin M: identification of an unusual fragment following high temperature trypsin proteolysis. (1972) (6)
REGIONAL DEFICIENCY OF SECRETORY IgA IN A PATIENT WITH COMBINED IMMUNODEFICIENCY OF THE ADA DEFICIENT TYPE (1979) (6)
Quantification of non-specific immunosuppressive factors. (1979) (6)
Milignant lymphoma with a monoclonal F(ab)μ fragment (1973) (6)
Immunosuppression by alpha-fetoprotein. (1975) (6)
Distinct IL-4 response mechanisms of the MHC gene Aα in different mouse B cell lines (1993) (6)
Fluorescent localization of immunoglobulins in the tissues of the cow. (1971) (6)
An Immunological Comparison Between Mouse α-Fetoprotein and the Uterine Estrogen Receptor (1978) (6)
Secretory component and serum immunoglobulin A deficiencies with intestinal autoantibody formation and autoimmune disease: a family study. (1982) (6)
Modeling of a possible conformational change associated with the catalytic mechanism in the hammerhead ribozyme. (1995) (6)
The modulation of Dicer regulates tumor immunogenicity in melanoma (2016) (5)
DECREASED LEVELS OF SECRETORY IMMUNOGLOBULINS FOLLOWING PROLONGED EXERCISE (1986) (5)
The human female reproductive tract: immunohistological localization of gamma A, gamma G, gamma M, secretory "piece," and lactoferrin. (1970) (5)
gamma-Glutamyl transpeptidase: relation to immunoglobulin A and free secretory component. (1976) (5)
VSSP abrogates murine ovarian tumor-associated myeloid cell-driven immune suppression and induces M1 polarization in tumor-associated macrophages from ovarian cancer patients (2022) (4)
Mechanisms of antibody formation. M. Holub and L. Jaroskova. New York, Academic Press, 1960. 385 pp., 214 illus., $10.00 (1962) (4)
59: EFFECTS OF PROLONGED INTENSE EXERCISE ON NATURAL KILLER CELLS (1987) (4)
The immunology and molecular biology of the gut-associated immune system. (1983) (4)
Dicer protein levels elevated by mild hyperthermia promote a pro-survival phenotype. (2017) (4)
The binding of alpha-1 antitrypsin to human IgA. (1974) (4)
C Activation in Skin Disease (1973) (4)
Granulocyte-macrophage colony-stimulating factor (GM-CSF) restores allostimulatory function to accessory cells in patients with AIDS (2002) (4)
Suppressive factors in amniotic fluid and newborn serum: is alpha-fetoprotein involved? (1978) (4)
The Effect of Mouse a-Fetoprotein on the Primary and Secondary Antibody Response (2003) (4)
Structure and Function of Immunoglobulin A (Part 2 of 3) (1972) (4)
Differential regulation of major histocompatibility complex class II expression and nitric oxide release by β-amyloid in rat astrocyte and microglia (1999) (4)
Inhibition of L-cell growth in agarose (ILGA): a simple inexpensive method for the detection and quantitation of factors inhibiting tumor cell growth. (1982) (4)
Differential regulation of TGF-beta 2 by hormones in rat uterus and mammary gland. (1996) (3)
Prolongation of survival of rat kidney allografts by transforming growth factor-beta 2. (1996) (3)
A new lymphocyte surface protein present in normal urine. II. Cellular distribution and biologic properties. (1980) (3)
Malignant lymphoma with a monoclonal F(ab)mu fragment. (1973) (2)
T and B cells in clinical disorders. (1977) (2)
Ultraviolet light-induced suppression of antigen presentation (1983) (2)
New areas arising from studies of secretory immunity. (1978) (2)
Eighteenth rheumatism review. Review of American and English literature for the years 1965 and 1966. (1968) (2)
Dicer protein levels elevated by mild hyperthermia promote a pro-survival phenotype (2017) (2)
Ataxia telangiectasia, immunodeficiency, and AFP: is there a relationship? (1978) (2)
The Secretion of Immunoglobulins by the Human Salivary Glands (1970) (2)
Effect of transforming growth factor-b on microglial MHC-class II (2000) (2)
Gut immune mechanisms. (1982) (2)
Flow cytometry in lymphoma. (1986) (2)
The human serum immunoglobulins. (1970) (2)
Antigenic properties of the Fab fragment of human IgM: antigenic determinants common to IgM and IgG. (1972) (1)
Selective transport of gamma A. (1969) (1)
A new lymphocyte surface protein present in normal urine. I. Isolation and physicochemical properties. (1980) (1)
The Nature of γA in Normal Urine1 (1970) (1)
Transferrin support of stimulated lymphocytes (1982) (1)
Distinct IL-4 response mechanisms of the MHC gene A alpha in different mouse B cell lines. (1993) (1)
Interaction of Antisera to the Secretory Component with FcαR (1987) (1)
Structure and Function of Immunoglobulin A (Part 3 of 3) (1972) (1)
Editorial: Aging and the regulation of immune reactivity. (1975) (1)
PBS-soluble substances with blood group activity from human epidermis and dermis. (1977) (1)
Oncogenes and cancer. (1986) (1)
Macrophage-related fibrinolysis in experimental disseminated histoplasmosis (1985) (1)
A predominant idiotype in the gut associated lymphoid tissue. (1987) (0)
A reply from Dr Tomasi (1993) (0)
3rd INTERNATIONAL CONVOCATION ON IMMUNOLOGY: BUFFALO, N.Y., JUNE 1972 (1973) (0)
Mechanisms and abnormalities of immune regulation. (1978) (0)
Mechanism of immune suppression by mouse amniotic fluid (1979) (0)
Fibrinolysis inExperimental Disseminated Histoplasmosis (1985) (0)
Amonoclonal IgM with antibody activity for human albumin in a patient with chronic lymphocytic leukemia (1982) (0)
Summary of IgA Workshop held at Wayne State University School of Medicine, Detroit, September 25–27, 1975 (1976) (0)
THE 1963 ANNUAL MEETING OF THE AMERICAN RHEUMATISM ASSOCIATION. (1963) (0)
Colonic and inflammatory bowel diseases. (1975) (0)
Modulation of c fms and c fgr expression in normal monocytic cells stimulated to proliferate with the csf 1 monocytic colony stimulating factor (1987) (0)
Diseases of intestinal absorption and secretion. (1975) (0)
THE LUNG IN RHEUMATOID DISEASE. (1965) (0)
Dicer regulates tumor immunogenicity in melanoma (2016) (0)
Interaction of antisera to the secretory component with Fc alpha R. (1987) (0)
STRUCTURE AND FUNCTION OF ALPHA-FETOPROTEI N (1977) (0)
High temperature trypsinolysis of human IgA: isolation of the Fcalpha fragment. (1976) (0)
ISOLATION, MOLECULAR SIZE AND SHAPE, COMPOSITION, AND NH,-TERMINAL AMINO ACID SEQUENCE (1976) (0)
Author index (1999) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Thomas B. Tomasi?

Thomas B. Tomasi is affiliated with the following schools: